Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression in invasive bladder cancer

Urological Research

Volumn 25, Issue 1, 1997, Pages 9-17

  Ravery, V ^a   Grignon, D ^b   Angulo, J ^b   Pontes, E ^b   Montie, J ^b   Crissman, J ^b   Chopin, D ^c  

^a CENTRE HOSPITALIER   (France)

^b WAYNE STATE UNIVERSITY   (United States)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

bladder cancer; EGF; growth factors; invasive tumors; prognosis; receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TRANSFORMING GROWTH FACTOR ALPHA; URINARY BLADDER NEOPLASMS;

EID: 0030951820     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00941900     Document Type: Article

References (39)

1. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HFM, Debruyne FMJ, Schalken JA (1993) Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 53:3241
2. Coombs LM, Oliver S, Sweeney E, Knowles M (1993) Immuno-cytochemical localization of c-erbB2 protein in transitional cell carcinoma of the urinary bladder. J Pathol 168:35
3. Cordon-Cardo C, Wartinger D, Petrylack D, Dalbagni G, Fair WF, Fuks Z, Renter VE (1992) Altered expression of retinobastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 84:1256
4. DePotter CR, Beghin C, Makar AP, Vandekerchkhove D, Roels HJ (1990) The neurooncogene protein as a predictive factor for hematogenous metastases in breast cancer patients. Int J Cancer 45.55
5. DiMarco E, Pierce JH, Aaronson SA, DiFiore PP (1990) Mechanisms by which EGF receptor and TGF alpha contribute to malignant transformation. Nat Imm Cell Reg 9:209
6. Fradet Y (1990) Biological markers of prognosis in invasive bladder cancer. Semin Oncol 17:533
7. Fukuyama R, Shimizu N (1991) Expression of epidermal growth factor (EGF) and the EGF receptor in human tissues. J Exp Zool 258.336
8. Gates RE, King LE, Jr (1985) Different forms of the epidermal growth factor receptor kinase have different autophosphorylation sites. Biochemistry 24:5209
9. Gleave ME, Hsieh JT, Wu HC, Hong SJ, Zhau HE, Guthrie PD, Chung LWK (1993) Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Cancer Res 53:5300
10. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ. Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD (1992) Identification of heregulin, a specific activator of p185 erbB2. Science 256:1205
11. International Union Against Cancer (1987) TNM classification of malignant tumors. 4th edn. Springer, Berlin Heidelberg New York
12. Klijn JG, Berns PM, Schmitz PI, Foekens JA (1992) The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review of 5232 patients. Endocr Rev 13.3
13. Lau JLT, Fowler JE, Jr, Ghosh L (1988) Epidermal growth factor in the normal and neoplastic kidney and bladder. J Urol 139:170
14. Limas C (1991) Relationship of epidermal growth factor receptor deductibility with the A,B,H blood group antigens:1 Emphasis on normal and neoplastic urothelium. Am J Pathol 139:131
15. Limas C, Bair R. Bernhart P (1993) Reddy P proliferation activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors. J Clin Pathol 46:810
16. Lipponen P (1993) Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int J Cancer 53:365
17. Lipponen P (1993) Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer. Eur J Cancer 29A:749
18. Marth C, Lang T. Cronauer MV, Doppler W, Zeimet AG, Bachmair F, Ullrich A, Dazembichler G (1992) Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells Int J Cancer 52:311
19. McCann A, Dervan PA, Johnston PA, Gullick WJ, Carney DN (1990) c-erbB-2 oncoprotein expression in primary human tumors. Cancer 65:88
20. Messing EM (1990) Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 50:2530
21. Messing EM, Reznikoff CA (1987) Normal and malignant human urothelium: In vitro effects of epidermal growth factor. Cancer Res 47:2230
22. Moriyama M, Akiyama T, Yamamoto T, Kawamoto T, Kato T, Sato K, Watanuki T, Hikage T, Katzuta N, Mori S (1991) Expression of c-erbB-2 gene product in urinary bladder cancer. J Urol 145:423
23. Mostofi FK, Sobin HL, Torlini H (1973) Histologic typing of urinary bladder tumors. World Health Organization, Geneva
24. Neal DE, Mellon K (1992) Epidermal growth factor receptor and bladder cancer: a review. Urol Int 48:365
25. Neal DE, Bennett MK, Hall RR, Marsh C, Abel P, Sainsbury JRC (1985) Epidermal growth factor receptors in human bladder cancer Composition of invasive and superficial tumours. Lancet 1:366
26. Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:1619
27. Nguyen PL, Swanson PE, Jaszcz W, Aeppli DM. Zhang G, Singleton TP, Ward S, Dykoski D, Harvey J, Niehans GA (1994) Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder: a multivariate survival analysis. Am J Clin Pathol 101:166
28. Nickell KA, Halper J, Moses HL (1983) Transforming growth factors in solid human malignant neoplasms. Cancer Res 43:1966
29. Press MF, Hung G, Godolphin W, Slamon DJ (1994) Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 54:2771
30. Sainsbury JRC, Malcom AJ, Appleton DR, Farndon JR, Harris AL (1985) Presence of EGF-R as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 38:1225
31. Sato K, Moriyama M, Mori S, Saito M, Watanuki T, Terada K, Okuhara E, Akiyama T, Toyoshima K, Yamamoto T, Kato T (1992) An immunohistologic evaluation of c-erbB-2 gene product in patients with urinary bladder carcinoma. Cancer 70:2493
32. Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ (1994) Epidermal growth factor receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer 57:508
33. Sherwin SA, Twardzik DR, Bohn WH, Cockley KD, Todaro GJ (1983) High molecular weight transforming growth factor activity in the urine of patients with disseminated cancer. Cancer Res 43:403
34. Swanson PE, Frierson HF, Jr, Wick MR (1992) c-erbB-2 (HER-2/neu) oncopeptide immunoreactivity in localized high grade transitional cell carcinoma of the bladder. Mod Pathol 5:531
35. Tribukait B, Gustafson H, Esposti PL (1982) The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumors: A study of 100 untreated cases. Br J Urol 54:130
36. Visscher DW, Castellani R, Wykes SM, Sarkar FH, Hussain ME (1993) Concurrent abnormal expression of ERBB-2, EGFR andp53 genes and clinical progression of breast carcinoma. Br Cancer Res Treat 28:261
37. Wood DP, Jr, Wartinger DD, Reuter V, Cordon-Cardo C, Fair WR, Chaganti SK (1991) DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder. J Urol 146:1398
38. Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Home CHW, Neal DE (1991) Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 63:967
39. Wright C, Mellon K, Neal DE, Johnson P, Corbett IP, Home CHW (1990) Expression of c-erbB-2 (neu) protein product in bladder cancer. Br J Cancer 62:764